Kana Yamamoto, M.D., Ph.D Physician, Medical Governance Research Institute "A Little Iken(Medical Opinion) Notebook" is a column in...

Masahiro Kami, M.D., Ph.D. President, Medical Governance Research Institute, Tokyo, Japan The COVID-19 vaccine KOSTAIVE, developed by Meiji Seika Pharma, a subsidiary of Meiji Holdings (Meiji HD), is drawing public attention. Social media is overflowing with rumors such as false claims that "shedding from vaccinated individuals can infect others around them." Shedding refers to the idea that after KOSTAIVE proliferates in the recipient’s body, some of it is released into the

Masaharu Tsubokura, M.D., Ph.D. Chief Professor, Department of Radiation Health Management, School of Medicine, Fukushima Medical...

Tetsuya Tanimoto, MD. Chairman of Accessible Railway Medical Services Tetsuikai Medical Corporation. Director of Navitas Clinic Kawasaki...

Masahiro Kami, M.D., Ph.D. President, Medical Governance Research Institute, Tokyo, Japan From May 25 to 27, the traditional festival of...

Akihiko Ozaki, M.D., Ph.D. Physician at the Medical Governance Research Institute Is there any influence from pharmaceutical companies on the medicines doctors prescribe? On August 10th, 2024, medical students and young doctors tackled this sensitive issue head-on at a symposium held at the 56th Japanese Society of Medical Education Conference held at Teikyo University. "56.9% of doctors meet with pharmaceutical companies at least once a week." The results of our questionna

In a recent discussion, Dr. Satoshi Umemura, a member of the House of Representatives and an internal medicine physician, engaged with...

Left: Tetsuya Tanimoto Tetsuya Tanimoto, MD. Chairman of Accessible Railway Medical Services Tetsuikai Medical Corporation. Director of...

By: Tetsuya Tanimoto, MD Chairman of Accessible Railway Medical Services Tetsuikai Medical Corporation Director of Navitas Clinic Kawasaki In the ever-evolving world of metabolic health management, we stand at a peculiar, almost mystical crossroads. On one side, a line-up of cutting-edge pharmaceuticals, the stars of which are GLP-1 receptor agonists, have appeared, almost from thin air. These drugs—sleek, precise, and modern—promise a life free from constant hunger and the w

Masahiro Kami, M.D., Ph.D. President, Medical Governance Research Institute, Tokyo, Japan The new coronavirus vaccine "Costaive," developed by Meiji Seika Pharma (a subsidiary of Meiji Holdings), has garnered significant public attention. Social media is flooded with misinformation, including claims that vaccinated individuals can infect others through 'shedding'. Meiji has initiated defamation lawsuits against anti-vaccine groups that have led the spread of these falsehoods.

Tetsuya Tanimoto, M.D. Medical Governance Research Institute, Tokyo, Japan In spring 2023, our pharmaceutical conflicts of interest research group participated in an international conference in Bath, UK. There, we had the pleasure of meeting Professor Tom Fahey from the Royal College of Surgeons in Ireland. While Ireland is a small nation with an estimated population of 5.28 million in 2023, it boasts a young demographic and impressive economic metrics. According to the IMF,

Masahiro Kami, M.D., Ph.D. President, Medical Governance Research Institute, Tokyo, Japan Anything made by humans cannot eliminate the...

Mutsuko Ohnishi, MD, Internal medicine physician in Boston, USA Continuing from the previous article, today’s topic is also about the...

Kana Yamamoto, M.D., Ph.D Physician, Medical Governance Research Institute The Japan Meteorological Agency (※1) announced on August 1st...

Accessible Rail Medical Services Tetsuikai, Navitas Clinic Kawasaki, Tetsuya Tanimoto, MD GLP-1 receptor agonists are very popular around...